The Research Steering Committee serves to coordinate activities across the consortium. Through twice-monthly conference calls and in-person meetings, its main functions are to establish guidelines for timely participation, overall analytic approach, selection of phenotypes, publication strategies, and approaches to authorship.
The RSC assists in the establishment of working groups for each phenotype of joint interest. It sets goals to aims for transparency, timely communication, effective coordination, and sharing of responsibilities, challenges, and opportunities among cohort members. The RSC encourages collaboration among members of the consortium and valuable non-consortium partners and may recruit other population-based cohort studies to join the consortium, may encourage joint ancillary-study grant applications to accomplish new scientific aims, and may form additional committees as needed.
Research Steering Committee Members:
| AGES
Susceptibility Study -- Reykjavik | | | |
|
|
|
National Institute of Aging |
|
National Institute of Aging
|
|
|
| | |
|
|
|
Boston University,
|
& Blood Institute
|
Boston University,
School of Public Health |
|
|
|
|
|
|
|
|
University of Texas
School of Public Health |
|
|
|
|
|
|
|
|
|
|
University of Washington |
Cedars-Sinai Medical Center
|
University of Washington |
Kenneth Rice, Ph.D.
University of Washington |
|
|
|
|
|
|
| |
Jaqueline Witteman, Ph.D.
Erasmus Medical Center | Albert Hofman, MD, Ph.D.,
Erasmus Medical Center |
Cornelia van Duijn, Ph.D.
Erasmus Medical Center |
Andre Uitterlinden, Ph.D.
Erasmus Medical Center | |
|
|
